<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://riskpublishing.com/wp-content/plugins/pretty-rss-feeds/xslt/pretty-feed.xsl" type="text/xsl" media="screen" ?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Key Risk Indicators for Pharmaceutical Companies &#8211; Risk Publishing</title>
	<atom:link href="https://riskpublishing.com/tag/key-risk-indicators-for-pharmaceutical-companies/feed/" rel="self" type="application/rss+xml" />
	<link>https://riskpublishing.com</link>
	<description>Connecting Risk Professionals</description>
	<lastBuildDate>Sun, 17 May 2026 20:37:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://riskpublishing.com/wp-content/uploads/2021/12/cropped-favicon2-32x32.png</url>
	<title>Key Risk Indicators for Pharmaceutical Companies &#8211; Risk Publishing</title>
	<link>https://riskpublishing.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Key Risk Indicators for Pharmaceutical Companies: FDA Compliance Examples</title>
		<link>https://riskpublishing.com/key-risk-indicators-for-pharmaceutical-companies/</link>
		
		<dc:creator><![CDATA[Chris Ekai]]></dc:creator>
		<pubDate>Thu, 14 May 2026 17:34:23 +0000</pubDate>
				<category><![CDATA[Key risk indicators]]></category>
		<category><![CDATA[key risk indicators]]></category>
		<category><![CDATA[Key Risk Indicators for Pharmaceutical Companies]]></category>
		<guid isPermaLink="false">https://riskpublishing.com/?p=35933</guid>

					<description><![CDATA[In June 2025 the FDA launched Elsa, an internal AI system that scans Form 483s, adverse event reports, and inspection outcomes to prioritize high-risk facilities. Within months, unannounced foreign inspections in India and China spiked. Sites that ran on intuition rather than measurable Key Risk Indicators for Pharmaceutical Companies started showing up on the warning ... <a title="Key Risk Indicators for Pharmaceutical Companies: FDA Compliance Examples" class="read-more" href="https://riskpublishing.com/key-risk-indicators-for-pharmaceutical-companies/" aria-label="Read more about Key Risk Indicators for Pharmaceutical Companies: FDA Compliance Examples">Read more</a>]]></description>
		
		
		
			</item>
	</channel>
</rss>
